Suzanne Cadarette and her research team at the University of Toronto are working with three community pharmacies, part of the Wholehealth Pharmacy Partners banner, on a quality improvement project to help patients with osteoporosis stay on schedule with their denosumab injections. As well, the initiative is testing the waters for pharmacists to inject the medication.

Funding from the Nashat Family Community Pharmacy Fund, part of CFP’s Innovation Fund, is enabling the three pharmacies to participate and benefit from automated alerts to follow up with patients to refill their denosumab prescription by the six-month due date. The funding will also be used for educational material and to remunerate pharmacies $15 for each administered injection. As well, participating pharmacists are documenting their interventions to support patients transitioning from the originator biologic, Prolia, to a biosimilar.

Get more details in this February 2026 news article.